|
|
Expression of the recombinant extracellular parts of leukocyte receptors AICL a NKR-P1CBALB
Čonka, Martin ; Novák, Petr (advisor) ; Cebecauer, Marek (referee)
v anglickém jazyce NK cells represent a population of lymphocytes which are able to kill certain tumor cells or virally infected cells. The subject of the diploma thesis is a mouse NK cell receptor mNKR- P1CBALB and a human leukocyte receptor hAICL. The mNKR-P1CBALB belongs to the activating receptors and is able to activate the cytotoxic functions of NK cells. The hAICL receptor is a ligand to the NKp80 which is an activating receptor of NK cells. Interaction between these two proteins leads to the activation of effector functions of NK cells as well. The aim of this work was the preparation of the recombinant extracellular parts of receptors mNKR-P1CBALB and hAICL, the optimalization of their in vitro refolding and the characterization of proteins using mass spectrometry. The proteins samples will be used for further structural study of the extracellular parts of these leukocytes receptors.
|
|
|
Mutagenesis and expression of protein NKp80, the activation receptor of human lymphocytes
Pazderová, Kristýna ; Vaněk, Ondřej (advisor) ; Ječmen, Tomáš (referee)
The subject of this study is a receptor NKp80, also known as killer cell lectin-like subfamily F, member 1 (KLRF1). It is an activating receptor which forms homodimers on the surface of natural killer (NK) cells. Receptor NKp80 binds to a ligand, AICL, which is naturally expressed on all myeloid cells. Upon a substantial increase in AICL expression, for example in cancer cell, the cell then becomes a target for an NK cells expressing the receptor NKp80. Ultimately, the complex NKp80:AICL is therefore a potential target for the immunotherapeutic treatment of myeloid leukaemia. The aim of the study was to the produce and purify a series of mutants of an extracellular domain of NKp80 by replacing cysteins by serines in a segment of extracellular domain called the stalk region. Here, by introducing the mutations, we studied their effect on homodimer formation. The proteins were prepared in HEK293S GnTI- cells using stable transfection. Altogether, we produced seven mutants with all possible combinations of mutations of the three cysteins in the stalk region. We then analysed the proteins using size exclusion chromatography and differential scanning fluorimetry. Lastly, we deglycosylated the proteins to verify that NKp80 is present in several glycoforms. Our results show that none of the variants of...
|
|
|
Preparation of receptor AICL in fusion with Fc fragment of human IgG
Runová, Alžbeta ; Vaněk, Ondřej (advisor) ; Hlouchová, Klára (referee)
Natural killer cells (NK cells) are one of the basic elements of innate immunity. They play a key role in immune response against virus-infected, cancerous or otherwise stressed cells. NK cells express surface activating and inhibitory receptors. Activating receptors trigger cytotoxic mechanisms that lead to the target cell's apoptosis. Inhibitory receptors provide cellular tolerance. The balance between these receptor signals determines the resultant NK cell response to the target cell. C-type lectin-like receptors include the activating receptor NKp80 and its ligand AICL. AICL is a myeloid-specific activating receptor expressed on tumor cells. The NKp80:AICL complex that assists in the cytolysis of malignant myeloid cells is being studied in the context of cancer immunotherapy. This bachelor thesis describes the preparation of vectors containing genes encoding AICL expression constructs, and the subsequent production of proteins in the human embryonic renal cell line (HEK293S GnTI- ). The expression constructs contain the extracellular domain of AICL, TEV protease site and Fc fragment. Two different constructs were prepared - one containing the native AICL sequence and the other carrying C87S mutation.
|
|
|
Preparation of human NK cell activation receptor NKp80 and its ligand AICL
Kalousková, Barbora ; Vaněk, Ondřej (advisor) ; Ingr, Marek (referee)
NK buňky (z angl. natural killer cells, přirozeně zabíječské buňky) hrají klíčovou roli při rozpoznávání a ničení nádorových, infikovaných nebo jinak pozměněných buněk. Na svém povrchu nemají antigenně specifické receptory, proto je řadíme mezi složky přirozené imunity. K rozpoznání cílových buněk slouží řada jiných povrchových receptorů. Inhibiční receptory zajišťují buněčnou toleranci, naopak aktivační receptory spouští cytotoxické mechanismy vedoucí k apoptóze a tedy lýzi buňky. Díky této vlastnosti jsou NK buňky intenzivně studovány v souvislosti s imunoterapií nádorových onemocnění. Jedním z aktivačních receptorů je NKp80 rozpoznávající svůj ligand AICL. Oba proteiny patří do rodiny receptorů podobných lektinům C-typu. Tento komplex se účastní nejenom přímé lýze maligních buněk myeloidního charakteru, ale má také důležitou roli v imunomodulaci zánětu. Předmětem této diplomové práce je příprava receptoru NKp80 a jeho ligandu AICL. Receptor NKp80 byl připraven v linii lidských embryonálních ledvinných buněk (HEK 293S GnTI- ). Byly připraveny stabilně transfekované linie produkující protein NKp80 konstitutivně nebo indukovatelně. Zapojení disulfidických můstků a obsazení N-glykosylačních míst proteinu NKp80 bylo ověřeno hmotnostní spektrometrií. Dále byl optimalizován postup Mgr. Jiřího Nového na...
|
|
|
Preparation and study of human NK cell receptor AICL
Nový, Jiří ; Vaněk, Ondřej (advisor) ; Novák, Petr (referee)
Natural killer cells, or NK cells are an integral component of innate immunity and fullfills the function of recognizing and killing tumor and virus-infected cells. Their function is regulated by signals produced by the interaction of inhibitory and stimulatory receptors on their surface with their specific ligands on the targer cell surface. NKp80 is an activating receptor of NK cells and forms specific complex with cell receptor AICL, both of which belong to the family of C-type lectin-like receptors. Overexpression of AICL receptor is preferably specific for tumor cells of myeloid character. This master's thesis describes the production of AICL mutated form by expression in Escherichia coli BL21 Gold (DE3) followed by isolation and in vitro renaturation of the target protein. In a previous study it was found that an odd number of cysteines in the extracelular lectin domain of AICL causes wrong folding of the protein. Substituting an odd cystein for serine at position 87 lead to stable soluble form of AICL with an even number of cysteines in conserved positions, typical for CTLD receptors. Correctness of the formation of disulfide bonds between cysteines was verified by mass spectrometry. Significant amount of the protein gained allowed for setting up a wide variety of crystallization conditions....
|
|
|
Expression of the recombinant extracellular parts of leukocyte receptors AICL a NKR-P1CBALB
Čonka, Martin ; Novák, Petr (advisor) ; Cebecauer, Marek (referee)
v anglickém jazyce NK cells represent a population of lymphocytes which are able to kill certain tumor cells or virally infected cells. The subject of the diploma thesis is a mouse NK cell receptor mNKR- P1CBALB and a human leukocyte receptor hAICL. The mNKR-P1CBALB belongs to the activating receptors and is able to activate the cytotoxic functions of NK cells. The hAICL receptor is a ligand to the NKp80 which is an activating receptor of NK cells. Interaction between these two proteins leads to the activation of effector functions of NK cells as well. The aim of this work was the preparation of the recombinant extracellular parts of receptors mNKR-P1CBALB and hAICL, the optimalization of their in vitro refolding and the characterization of proteins using mass spectrometry. The proteins samples will be used for further structural study of the extracellular parts of these leukocytes receptors.
|
guest ::
